Cellular and T cell engager Immunotherapy
Ide-cel real-world (RW) and clinical trial long-term safety experience: a special focus on movement and neurocognitive treatment adverse events (MNT AEs) and second primary malignancies (SPMs)
Rafat Abonour, Professor
Director Plasma cell disorders
Indiana University School of Medicine
Indianapolis, Indiana, United States